Recently, I went with my mother to what was supposed to be a routine appointment — one of those checkups we had done so many times before. But this time, the doctor paused while listening to her heart and heard a murmur. Suddenly, a flurry of tests followed: EKG, echocardiogram, bloodwork. I watched my mother — someone who has managed high cholesterol and blood pressure for years — face a new wave of uncertainty.
In that exam room, I was reminded how heart disease often develops in the background — slow and silent — until a moment like this brings it into sharp focus. Her results revealed not one problem but several: thickened heart muscle, aortic stenosis, narrowing of the carotid artery. Years of small, manageable risks had quietly built up, waiting for the right moment to be noticed. The heart had been speaking all along. We had simply not yet learned to listen.
This is not just my mother’s story. I see this slow, silent progression in many patients — people who seem healthy until, suddenly, they are not. The heart works tirelessly over a lifetime. When it finally stops, so do we. But between now and that moment, it has been sending signals for years. The question is whether anyone is present enough to receive them.
Cardiovascular disease is not an event. It is a process — one that researchers now believe may begin as early as adolescence, decades before any symptom appears. The atlas of atherosclerosis, documented by Herbert Stary and expanded by Peter Libby, describes a progression that unfolds quietly in arterial walls while a person goes about the business of living.
It begins with the endothelium — the delicate single-cell lining of every blood vessel in the body. Damage to this lining is the first chapter of the story. Smoking does it chemically. High blood pressure does it mechanically, with years of relentless hydraulic force. Once breached, the endothelium becomes permeable. And what enters changes everything.
LDL cholesterol — the particle most people know as “bad cholesterol” — penetrates the damaged endothelium and becomes trapped in the arterial wall. There, it oxidizes. The oxidized LDL triggers an immune response: the body sends monocytes to contain the threat. Those monocytes transform into macrophages, consuming the oxidized lipid until they become what researchers call foam cells — lipid-laden immune cells embedded in the arterial wall. This is the beginning of a plaque.
The real culprit, as the research makes clear, is not cholesterol itself but lipid oxidation — the inflammatory cascade triggered when LDL becomes oxidized inside the arterial wall. Oxidative stress, reactive oxygen species, endothelial dysfunction: these are the mechanisms of a slow fire burning inside the vasculature, visible only when the damage has accumulated enough to alter structure, restrict flow, or rupture.
Lipoprotein(a) — Lp(a) — is a particle that circulates in the blood, picking up fragments of oxidized lipid molecules and carrying them toward the arterial wall. Unlike LDL, Lp(a) is almost entirely determined by genetics. It cannot be meaningfully reduced through diet or lifestyle. Black patients carry elevated Lp(a) levels at significantly higher rates than white patients — a biological reality that contributes to the documented disparity in cardiovascular outcomes across racial lines.
Lp(a) is prothrombotic — it promotes clotting — and it accelerates arterial plaque formation. It is one of the most significant independent risk factors for cardiovascular disease. It is also one of the least tested for in routine clinical practice. Most patients have never heard of it. Many physicians do not test for it unless a patient presents with premature cardiovascular disease or a strong family history.
If you have a family history of heart disease, particularly early-onset, ask specifically about Lp(a) testing. It is a single blood draw. The result does not change, but knowing it shapes every subsequent conversation about your cardiovascular risk.
Cholesterol itself is not the enemy. It is essential — for cell membranes, for hormone production, for the synthesis of vitamin D. The old belief that eating cholesterol-rich foods directly causes heart disease has been substantially revised by decades of research. Most cholesterol in the body is produced by the liver and other cells, not absorbed from food. The egg white omelet craze — the elimination of yolk to avoid dietary cholesterol — was largely a response to a misunderstood mechanism.
What matters is not cholesterol in isolation but the full lipid picture: LDL particle size and oxidation, HDL function, triglycerides, and the increasingly important apolipoprotein B (apoB) count — a measure of the total number of atherogenic particles circulating in the blood. A person can have a “normal” LDL number while carrying a dangerous number of small, dense LDL particles. ApoB captures what total cholesterol misses.
Ask your physician about apoB. If it is not part of your standard lipid panel, request it specifically. It is one of the most predictive markers of cardiovascular risk available — and it is almost never discussed in a routine appointment.
We have been taught to associate cardiovascular risk with a particular body type — overweight, sedentary, visibly unhealthy. The reality is considerably more complex. Visceral fat — the fat stored around internal organs rather than beneath the skin — is metabolically active and inflammatory regardless of a person’s outward appearance. A person of normal weight can carry dangerous levels of visceral fat. A person who appears lean and fit can have arterial plaques accumulating for years.
Fat stored around the organs, not visible from the outside. Metabolically active, inflammatory, and a significant driver of insulin resistance and cardiovascular risk regardless of overall weight.
Sarcopenia — the loss of muscle tissue with age — is an independent cardiovascular risk factor. Being underweight or frail carries as much risk as obesity in older adults. Muscle is metabolically protective.
Borderline insulin resistance — often overlooked because it falls short of a diabetes diagnosis — accelerates endothelial damage and atherosclerosis. The metabolic trifecta discussed in our diabetes piece is directly relevant here.
Elevated CRP (C-reactive protein) and other inflammatory markers signal a vascular environment in which atherosclerosis progresses more rapidly. Chronic stress, poor sleep, and systemic inflammation from gut dysbiosis all contribute.
A parent or sibling with heart disease before age 55 (men) or 65 (women) significantly elevates personal risk. Lp(a), familial hypercholesterolemia, and inherited inflammatory tendencies do not respond to lifestyle alone.
Blood pressure that is consistently in the high-normal range — not yet hypertension, but trending there — is doing mechanical damage to the endothelium over years. Trajectory matters as much as any single reading.
Cardiovascular disease announces itself — but not always in the language we expect. The symptoms most people associate with heart disease — crushing chest pain, dramatic collapse — are often the late chapter of a story that began with much quieter signals years earlier.
No symptoms. Atherosclerosis progressing in arterial walls. Endothelial dysfunction beginning. This phase can last decades and is only detectable through imaging or advanced blood markers.
The body signals: fatigue that doesn’t resolve with rest, subtle changes in exercise tolerance, borderline lab results that fall within range but are trending.
Plaques grow and begin to restrict blood flow. The heart works harder to compensate. Blood pressure rises. The system is under strain it was not designed to sustain indefinitely.
The body signals: shortness of breath on exertion that wasn’t there before, occasional chest tightness, swollen ankles, a sense that the body is working harder than the activity warrants.
A plaque ruptures, triggering a clot. Or a vessel narrows enough to starve the heart or brain of oxygen. This is the event — the heart attack, the stroke — that most people think of as the beginning of heart disease. It is not the beginning. It is the culmination of years.
The body signals: chest pain radiating to the arm or jaw, sudden severe headache, facial drooping, arm weakness, slurred speech. These require emergency response, not a wait-and-see approach.
Cardiovascular disease is among the most preventable of all chronic conditions. The earlier the intervention — whether lifestyle, medication, or both — the more of the trajectory can be altered. A CT calcium score can detect calcified plaque years before symptoms appear. ApoB and Lp(a) testing can quantify risk that standard cholesterol panels miss entirely.
The body responds: to movement, to anti-inflammatory eating, to blood pressure management, to sleep, to stress reduction, to the medications that work — and to a patient who finally understands what their vasculature has been trying to say.
Heart disease cannot always be cured. But the research is unambiguous: it can be substantially delayed, slowed, and in some cases partially reversed. The interventions that matter most are not dramatic. They are sustained.
Movement is the single most protective intervention available — more protective, per unit of effort, than almost any medication. Resistance training builds the muscle mass that protects metabolic health. Aerobic exercise improves endothelial function directly. A thirty-minute walk, most days, measurably reduces cardiovascular risk over time. Not because it burns calories. Because it changes the biology of the vessel wall.
Sleep matters in ways that are still underappreciated. Chronic sleep deprivation elevates cortisol, raises blood pressure, drives inflammation, and accelerates the oxidative stress that is the engine of atherosclerosis. The heart does its most important repair work during deep sleep. Protecting that window is not optional.
Diet matters — but not in the simple way we were taught. The anti-inflammatory diet that protects the vasculature is not about eliminating fat or cholesterol. It is about reducing the processed foods, refined carbohydrates, and industrial seed oils that drive oxidative stress and systemic inflammation. It is about the omega-3 fatty acids that reduce triglycerides and stabilize arterial plaque. It is about the food that communicates with the body in a language the body understands.
Stress is a cardiovascular risk factor with its own biological mechanism. Chronic psychological stress activates the sympathetic nervous system, raises blood pressure, elevates inflammatory markers, and promotes the clotting cascade. It is not a soft risk. It is a hard one. Managing it is not a lifestyle choice — it is a clinical intervention.